These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

652 related articles for article (PubMed ID: 31361565)

  • 1. Multidrug- and Extensively Drug-Resistant
    Romanin P; Palermo RL; Cavalini JF; Fávaro LDS; De Paula-Petroli SB; Fernandes EV; Dos Anjos Szczerepa MM; Tognim MCB; Yamada-Ogatta SF; Carrara-Marroni FE; Yamauchi LM
    Microb Drug Resist; 2019 Nov; 25(9):1365-1373. PubMed ID: 31361565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acinetobacter baumannii clonal lineages I and II harboring different carbapenem-hydrolyzing-β-lactamase genes are widespread among hospitalized burn patients in Tehran.
    Mahdian S; Sadeghifard N; Pakzad I; Ghanbari F; Soroush S; Azimi L; Rastegar-Lari A; Giannouli M; Taherikalani M
    J Infect Public Health; 2015; 8(6):533-42. PubMed ID: 26111484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergence of carbapenem non-susceptible multidrug resistant Acinetobacter baumannii strains of clonal complexes 103(B) and 92(B) harboring OXA-type carbapenemases and metallo-β-lactamases in Southern India.
    Saranathan R; Vasanth V; Vasanth T; Shabareesh PR; Shashikala P; Devi CS; Kalaivani R; Asir J; Sudhakar P; Prashanth K
    Microbiol Immunol; 2015 May; 59(5):277-84. PubMed ID: 25726848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The first nationwide multicenter study of Acinetobacter baumannii recovered in Serbia: emergence of OXA-72, OXA-23 and NDM-1-producing isolates.
    Lukovic B; Gajic I; Dimkic I; Kekic D; Zornic S; Pozder T; Radisavljevic S; Opavski N; Kojic M; Ranin L
    Antimicrob Resist Infect Control; 2020 Jul; 9(1):101. PubMed ID: 32631451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Epidemiology of Carbapenem-Resistant Acinetobacter baumannii in a Tertiary Care Hospital in Egypt: Clonal Spread of blaOXA-23.
    El Bannah AMS; Nawar NN; Hassan RMM; Salem STB
    Microb Drug Resist; 2018 Apr; 24(3):269-277. PubMed ID: 28783427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.
    Jain M; Sharma A; Sen MK; Rani V; Gaind R; Suri JC
    Microb Pathog; 2019 Mar; 128():75-81. PubMed ID: 30562602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence of carbapenem-resistant Acinetobacter baumannii in hospitals in Pakistan.
    Hasan B; Perveen K; Olsen B; Zahra R
    J Med Microbiol; 2014 Jan; 63(Pt 1):50-55. PubMed ID: 24085817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterization of carbapenem-insensitive Acinetobacter baumannii in Egypt.
    Al-Agamy MH; Khalaf NG; Tawfick MM; Shibl AM; El Kholy A
    Int J Infect Dis; 2014 May; 22():49-54. PubMed ID: 24607428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissemination of bla
    Leungtongkam U; Thummeepak R; Wongprachan S; Thongsuk P; Kitti T; Ketwong K; Runcharoen C; Chantratita N; Sitthisak S
    Microb Drug Resist; 2018; 24(1):55-62. PubMed ID: 28594634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial Susceptibility and Molecular Characterization of Clinical Strains of
    Shah MW; Yasir M; Farman M; Jiman-Fatani AA; Almasaudi SB; Alawi M; El-Hossary D; Azhar EI
    Microb Drug Resist; 2019 Nov; 25(9):1297-1305. PubMed ID: 31216221
    [No Abstract]   [Full Text] [Related]  

  • 11. A prospective multicenter study on the evaluation of antimicrobial resistance and molecular epidemiology of multidrug-resistant Acinetobacter baumannii infections in intensive care units with clinical and environmental features.
    Boral B; Unaldi Ö; Ergin A; Durmaz R; Eser ÖK;
    Ann Clin Microbiol Antimicrob; 2019 Jul; 18(1):19. PubMed ID: 31266519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and Mechanisms of Carbapenem Resistance Among
    Benmahmod AB; Said HS; Ibrahim RH
    Microb Drug Resist; 2019 May; 25(4):480-488. PubMed ID: 30394846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of colistin against multidrug-resistant Acinetobacter baumannii isolates harboring blaOXA-23-like and blaOXA-24-like genes: A multicenter based study.
    Khanjani S; Sedigh Ebrahim-Saraie H; Shenagari M; Ashraf A; Mojtahedi A; Atrkar Roushan Z
    Acta Microbiol Immunol Hung; 2020 Mar; 67(3):182-186. PubMed ID: 32160785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of carbapenem-resistant Acinetobacter baumannii clinical isolates from Egyptian patients.
    Hassan RM; Salem ST; Hassan SIM; Hegab AS; Elkholy YS
    PLoS One; 2021; 16(6):e0251508. PubMed ID: 34166384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outbreak of carbapenem-resistant Acinetobacter baumannii carrying the carbapenemase OXA-23 in ICU of the eastern Heilongjiang Province, China.
    Zhao Y; Hu K; Zhang J; Guo Y; Fan X; Wang Y; Mensah SD; Zhang X
    BMC Infect Dis; 2019 May; 19(1):452. PubMed ID: 31113374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of carbapenem resistance in Acinetobacter baumannii: an 18-year longitudinal study from a medical center in northern Taiwan.
    Ku WW; Kung CH; Lee CH; Tseng CP; Wu PF; Kuo SC; Chen TL; Lee YT; Wang FD; Fung CP
    J Microbiol Immunol Infect; 2015 Feb; 48(1):57-64. PubMed ID: 24064289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OXA beta-lactamase-mediated carbapenem resistance in Acinetobacter baumannii.
    Amudhan SM; Sekar U; Arunagiri K; Sekar B
    Indian J Med Microbiol; 2011; 29(3):269-74. PubMed ID: 21860108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterization of oxacillinases among carbapenem-resistant Acinetobacter baumannii nosocomial isolates in a Saudi hospital.
    Elabd FM; Al-Ayed MS; Asaad AM; Alsareii SA; Qureshi MA; Musa HA
    J Infect Public Health; 2015; 8(3):242-7. PubMed ID: 25466594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OXA-Carbapenemases Present in Clinical Acinetobacter baumannii-calcoaceticus Complex Isolates from Patients in Kurdistan Region, Iraq.
    Ganjo AR; Maghdid DM; Mansoor IY; Kok DJ; Severin JA; Verbrugh HA; Kreft D; Fatah MH; Alnakshabandi AA; Dlnya A; Hammerum AM; Ng K; Goessens W
    Microb Drug Resist; 2016 Dec; 22(8):627-637. PubMed ID: 27003287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct Genetic Diversity of Carbapenem-Resistant Acinetobacter baumannii from Colombian Hospitals.
    Correa A; Del Campo R; Escandón-Vargas K; Perenguez M; Rodríguez-Baños M; Hernández-Gómez C; Pallares C; Perez F; Arias CA; Cantón R; Villegas MV
    Microb Drug Resist; 2018; 24(1):48-54. PubMed ID: 28570118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.